Top compounds associated with response to AP000769.1


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.03
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.079 0.03
mRNA Bax channel blocker CTRPv2 pan-cancer AAC 0.08 0.03
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC -0.078 0.04
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.07 0.04
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.073 0.04
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.04
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.073 0.05
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC 0.13 0.05
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.05
Download CSV